Intel stock price slips after hours as Nvidia-Meta chip deal puts server CPUs in focus

Intel stock price slips after hours as Nvidia-Meta chip deal puts server CPUs in focus

February 19, 2026

New York, Feb 18, 2026, 18:17 EST — After-hours.

  • Intel fell 1.6% on Wednesday and was flat after hours near $45.46
  • Nvidia’s Meta deal includes Arm-based CPUs that compete with Intel and AMD
  • Intel said CFO David Zinsner will speak at Morgan Stanley’s TMT conference on March 4

Intel Corp (NASDAQ: INTC) shares fell for a second straight session on Wednesday, closing down 1.6% at $45.46 and holding flat in after-hours trading. The stock ranged from $44.88 to $46.77, with about 63 million shares changing hands. It ended Tuesday down 1.3%.

The move came a day after Nvidia said it had signed a multiyear agreement to sell Meta Platforms millions of its current and future artificial intelligence chips, including CPUs that compete with Intel and Advanced Micro Devices, Reuters reported. Nvidia executive Ian Buck said Grace central processors can “use half the power” for some common tasks such as running databases. Reuters

That matters for Intel because server CPUs still set the pace for the data-center stack, even when GPUs do the heavy lifting for AI. If big cloud customers start standardizing on Arm-based chips — processors built on Arm Holdings’ design rather than Intel’s x86 — Intel’s pricing power and share come under strain.

Nvidia shares rose 1.5% on Wednesday, while AMD fell 1.5% and Meta edged up 0.6%.

In a separate press release, Nvidia said Meta will expand deployment of Arm-based Grace CPUs and use “millions” of Blackwell and Rubin GPUs, plus networking gear, in its data centers. “No one deploys AI at Meta’s scale,” Nvidia CEO Jensen Huang said, while Meta CEO Mark Zuckerberg said, “We’re excited to expand our partnership with NVIDIA.” NVIDIA Investor Relations

For Intel investors, the read-through is simple: Nvidia wants to be more than the GPU supplier in the rack. It is pitching Grace and its next-generation Vera CPU as a lower-power option for everyday work like databases, and for so-called AI agents — software that can plan and take actions for a user.

Intel said on Wednesday its CFO, David Zinsner, will take part in a fireside chat — a Q&A-style talk — at Morgan Stanley’s Technology, Media & Telecom Conference on March 4. A live webcast and replay will be available on Intel’s investor relations site, the company said.

The market is still working through Intel’s latest outlook. In late January, the chipmaker forecast first-quarter revenue and profit below estimates and said it was struggling to meet demand for server chips used in AI data centers.

But the near-term risks remain uneven. If Arm-based alternatives gain traction faster, or if Intel’s supply constraints linger, the stock could struggle to find support even as parts of the semiconductor group hold up.

Traders will look for follow-through when the regular session resumes on Thursday, and for any analyst notes that put numbers on the Meta-Nvidia shift. Zinsner’s March 4 appearance is the next fixed point on the calendar for Intel shares.

Stock Market Today

  • 3 ASX 200 Healthcare Shares to Buy Amid Sector Downturn
    June 2, 2026, 10:56 PM EDT. The S&P/ASX 200 Health Care Index has dropped roughly 34% year-to-date and 47% over 12 months, underperforming the broader ASX 200 which is mostly flat. This sector-wide decline, driven by macroeconomic pressures and regulatory uncertainty, has pushed healthcare stocks to multi-year lows, presenting buying opportunities. Key picks include ResMed (ASX: RMD), down 28%, seen as undervalued due to its leadership in sleep health. Fisher & Paykel (ASX: FPH) rebounded 14% post strong FY26 results, with broker consensus bullish on its 21% upside potential. Pro Medicus (ASX: PME) gained 21% after a significant US contract renewal, despite still declining 28% year-to-date. Analysts rate these stocks as strong buys, highlighting opportunities in a beaten-down sector.